[go: up one dir, main page]

Nesbitt et al., 1994 - Google Patents

Effect of substrate on mass release from ethylcellulose latex coated pellets

Nesbitt et al., 1994

Document ID
7113058970464566077
Author
Nesbitt R
Mahjour M
Mills N
Fawzi M
Publication year
Publication venue
Journal of controlled release

External Links

Snippet

The release of water soluble substrates from Aquacoat coated pellets was through water- filled channels. Each pellet works like a mini osmotic pump with many orifices (pores). The energy to drive the system was supplied by the osmotic pressure differences generated …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases; Films; Fibres of the matrix type containing drug

Similar Documents

Publication Publication Date Title
Zentner et al. The controlled porosity osmotic pump
US5612059A (en) Use of asymmetric membranes in delivery devices
Ozturk et al. Mechanism of release from pellets coated with an ethylcellulose-based film
EP0357369B1 (en) The use of asymetric membranes in delivery devices
EP1010423B1 (en) Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production
JP2750150B2 (en) Osmotic continuous dispersible oral projection system containing pharmaceutically acceptable active agents with improved core membrane adhesion properties
JP4703470B2 (en) Controlled release formulation coated with ethyl cellulose aqueous dispersion
EP1027888B1 (en) Osmotic system for delivery of solid amorphous dispersions of drugs
JP2847326B2 (en) Supported liquid membrane delivery device
JP2003528910A (en) Preparation of controlled release formulations
SK143296A3 (en) Controlled-release dosage forms of azithromycin
CA2000932C (en) Oral pharmaceutical controlled release multiple unit dosage form
Zhang et al. Bead coating. I. Change in release kinetics (and mechanism) due to coating levels
FI65911C (en) OEVERDRAG SOM GARANTERAR EN KONTROLLERAD FRIGOERING AV AKTIVA BESTAONDSDELAR UR BIOLOGISKT AKTIVA PREPARAT SPECIELLT UR FAMACEUTISKA PREPARAT OCH FOERFARANDE FOER FRAMSTAELLNING A V IOLOGISKT AKTIVA VEPARAT UEP
Nesbitt et al. Effect of substrate on mass release from ethylcellulose latex coated pellets
Yuen et al. Development and in-vitro evaluation of a multiparticulate sustained release theophylline formulation
Kranz et al. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers
US20040058000A1 (en) Controlled release capsule for delivery of liquid formulation
WO2002049621A1 (en) Enteric-coated drug formulations and their manufacture
WO2004112746A1 (en) Controlled release-drug delivery system for oral administration
WO2004058257A1 (en) Controlled release formulation comprising benzimidazole derivatives or pharmaceutically acceptable salts thereof with increased stability and method for preparing the same
Mehta Factors in the development of oral controlled release dosage forms
Kim et al. Influence of water soluble additives and HPMCP on drug release from sureleaseê-coated pellets containing tamsulosin hydrochloride
Nimmannit et al. Microencapsulation of drugs by the coacervation technique using ethylcellulose and acrylate-methacrylate copolymer as wall materials
Jambhekar et al. Influence of formulation and other factors on the release of chlorpheniramine mateate from polymer coated beads